Reasons for participation in optional pharmacokinetic studies in children with cancer: A Children's Oncology Group Phase 1 Consortium study

Pediatric Blood and Cancer

Volumn 55, Issue 1, 2010, Pages 119-122

  Berg, Stacey L ^a   Winick, Naomi ^b   Ingle, Ashish Mark ^c   Adamson, Peter C ^d   Blaney, Susan M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c CHILDREN S ONCOLOGY GROUP   (United States)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Cancer; Children; Ethics; Pharmacokinetics; Phase 1 studies

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; ATTITUDE TO HEALTH; CHILD; CLINICAL RESEARCH; FEMALE; HEALTH CARE PERSONNEL; HUMAN; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; NEOPLASM; PRESCHOOL CHILD; PRIORITY JOURNAL; PUBLICATION; QUESTIONNAIRE; SCHOOL CHILD;

ADOLESCENT; ADULT; ALTRUISM; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS, PHASE I AS TOPIC; FEMALE; HUMANS; MALE; NEOPLASMS; PATIENT PARTICIPATION; QUESTIONNAIRES; YOUNG ADULT;

EID: 77953243710     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22529     Document Type: Article

References (18)

1. Constitutional law - substantive due process - en banc D.C. Circuit rejects fundamental right to experimental medications. - Abigail Alliance for Better Access to Developmental Drugs v. von Eschenbach, 495 F.3d 695 (D.C. Cir. 2007)(en banc), cert. denied, 128 S. Ct. 1069 (2008). Harv Law Rev 2008; 121: 1685-1692.
2. Brown AP, Wendler DS, Camphausen KA, et al. Performing nondiagnostic research biopsies in irradiated tissue: A review of scientific, clinical, and ethical considerations. J Clin Oncol 2008;26:3987-3994.
3. Anderson BD, Adamson PC, Weiner SL, et al. Tissue collection for correlative studies in childhood cancer clinical trials: Ethical considerations and special imperatives. J Clin Oncol 2004;22:4846-4850.
4. Appelbaum PS, Roth LH, Lidz C. The therapeutic misconception: Informed consent in psychiatric research. Int J Law Psychiatry 1982;5:319-329.
5. Agrawal M, Grady C, Fairclough DL, et al. Patients' decision-making process regarding participation in phase I oncology research. J Clin Oncol 2006;24:4479-4484. (Pubitemid 46630987)
6. Hutchison C. Phase I trials in cancer patients: Participants' perceptions. Eur J Cancer Care (Engl) 1998;7:15-22. (Pubitemid 128657860)
7. Miller M. Phase I cancer trials. A collusion of misunderstanding. Hastings Cent Rep 2000;30:34-43.
8. Weinfurt KP, Castel LD, Li Y, et al. The correlation between patient characteristics and expectations of benefit from Phase I clinical trials. Cancer 2003;98:166-175. (Pubitemid 36741139)
9. Weinfurt KP, Sulmasy DP, Schulman KA, et al. Patient expectations of benefit from phase I clinical trials: Linguistic considerations in diagnosing a therapeutic misconception. Theor Med Bioeth 2003;24:329-344. (Pubitemid 37336581)
10. Agulnik M, Oza AM, Pond GR, et al. Impact and perceptions of mandatory tumor biopsies for correlative studies in clinical trials of novel anticancer agents. J Clin Oncol 2006;24:4801-4807. (Pubitemid 46655611)
11. Horng S, Emanuel EJ, Wilfond B, et al. Descriptions of benefits and risks in consent forms for phase 1 oncology trials. N Engl J Med 2002;347:2134-2140. (Pubitemid 36015126)
12. Jacoby L. The role of altruism in parental decision-making for childhood cancer clinical trials - Further questions to explore. Am J Bioeth 2006;6:52.
13. Joffe S. Altruistic discourse and therapeutic misconception in research informed consent. Am J Bioeth 2006;6:53-54. (Pubitemid 44451639)
14. Ladd RE, Forman E. Altruistic motives reconsidered. Am J Bioeth 2006;6:55-56.
15. Simon C, Eder M, Kodish E, et al. Altruistic discourse in the informed consent process for childhood cancer clinical trials. Am J Bioeth 2006;6:40-47. (Pubitemid 44451634)
16. Spriggs M. Can children be altruistic research subjects? Am J Bioeth 2006;6:49-50.
17. Wasson K. Altruism and pediatric oncology trials: It does not tip the decision-making scales. Am J Bioeth 2006;6:48. (Pubitemid 44451635)
18. Cohen MZ, Slomka J, Pentz RD, et al. Phase I participants' views of quality of life and trial participation burdens. Support Care Cancer 2007;15:885-890. (Pubitemid 47387509)